Turner syndrome and multiple-marker screening

Clinical Chemistry

Volumn 45, Issue 12, 1999, Pages 2259-2261

  Ruiz, Cristina ^a,b   Lamm, Felicia ^a   Hart, P Suzanne ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b ADVOCATE CHRIST MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; AMNIOCENTESIS; ARTICLE; CHROMOSOME ABERRATION; CYSTIC LYMPHANGIOMA; DOWN SYNDROME; ENZYME IMMUNOASSAY; FEMALE; FETUS HYDROPS; FETUS RISK; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PREGNANCY TERMINATION; PRENATAL SCREENING; RADIOIMMUNOASSAY; SCREENING TEST; SECOND TRIMESTER PREGNANCY; TRISOMY; TURNER SYNDROME;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; EDEMA; ESTRADIOL; FEMALE; FETAL DISEASES; GENETIC COUNSELING; GESTATIONAL AGE; HUMANS; LYMPHANGIOMA, CYSTIC; MASS SCREENING; MATERNAL AGE; NEONATAL SCREENING; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; RISK; TURNER SYNDROME;

EID: 0032737336     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 1. Canick JA, Palomaki GE, Osathanodh R. Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 1990;10:546-8.
2. 2. Greenberg F, Schmidt D, Darnule AT, Weyland BR, Rose E, Alpert E. Maternal serum α-fetoprotein, β-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies. Am J Obstet Gynecol 1992;166:1388-92.
3. 3. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Saller DN, Panizza DS. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum α-fetoprotein, unconjugated estriol, and human chorionic gonadotropin. Prenat Diagn 1992;12:925-30.
4. 4. Knowles S, Flett P. Multiple marker screen positively in the presence of hydrops fetalis. Prenat Diagn 1994;14:403-5.
5. 5. Saller DN, Canick JA, Schwartz S, Blitzer MG. Multiple marker screening in pregnancies with hydropic and nonhydropic Turner syndrome. Am J Obstet Gynecol 1992;167:1021-4.
6. 6. Wenstrom KD, Williamson RA, Grant SA. Detection of fetal Turner syndrome with multiple marker screening. Am J Obstet Gynecol 1994;170:570-3.
7. 7. Laundon CH, Spencer K, Macri JN, Anderson RW, Buchanan PD. Free βhCG screening of hydropic and non-hydropic Turner syndrome. Prenat Diagn 1996;16:853-6.
8. 8. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down syndrome in early pregnancy. Br Med J 1988;297:883-7.
9. 9. Palomaki GE, Haddow JE, Knight GJ, Wald NJ, Kennard A, Canick JA, et al. Risk-based prenatal screening for trisomy 18 using α-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 1995;15: 713-23.
10. 10. ACOG Committee. ACOG Committee opinion on Down syndrome screening. Int J Gynecol Obstet 1994;47:186-90.
11. 11. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, et al. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynecol 1988;95:334-41.
12. 12. MacDonald ML, Wagner RM, Slotnick RN. Sensitivity and specificity of screening for Down syndrome with α-fetoprotein, hCG, unconjugated estriol and maternal age. Obstet Gynecol 1991;77:63-8.
13. 13. Saller DN, Carpenter MW, Canick JA. A prenatal screening program using AFP, UE3, and HCG: detection of pregnancies complicated by hydropic changes [Abstract]. Am J Obstet Gynecol 1991;164:355.
14. 14. Wenstrom KD, Boots LR, Cosper PC. Multiple marker screening test: identification of fetal cystic hygromas, hydrops, and sex chromosome aneuploidy. J Matern Fetal Med 1996;5:31-5.
15. 15. Saller DN Jr, Canick JA, Oyer CE. The detection of non-immune hydrops through second-trimester maternal serum screening. Prenat Diagn 1996; 16:431-5.
16. 16. Aranguren G, Garcia-Minaur S, Loridan L, Uribarren A, Vargas LM, Rodriguez-Soriano J. Multiple marker screen positive results in Noonan syndrome. Prenat Diagn 1996;16:183-4.
17. 17. Lambert-Messelian GM, Saller DN Jr, Tumber MB, French CA, Peterson CJ, Canick JA. Second trimester maternal serum inhibin A levels in fetal trisomy 19 and Turner syndrome with and without hydrops. Prenat Diagn 1998;1061-7.